Dieter-Gericke and Daniel Haeusermann

Homburger, Lenz & Staehelin advise on vVARDIS IPO

Homburger advised Zug-based dental med-tech company vVARDIS Holding on the IPO of its Class A ordinary shares on the New York Stock Exchange, where they trade under the ticker symbol VVVV. Moreover, Lenz & Staehelin acted as Swiss counsel to the underwriters.

The offering was priced at USD 18.00 per share and raised gross proceeds of approximately USD 175m.

Deal details

The IPO comprised 9,722,223 Class A ordinary shares. vVARDIS granted the underwriters a 30-day option to purchase up to 1,458,333 additional Class A ordinary shares at the public offering price to cover over-allotments. If the option is exercised in full, proceeds could rise to USD 201.3m.

vVARDIS, headquartered in Zug, Switzerland, develops non-invasive, drill-free treatments for dental professionals under the Curodont brand.

Goldman Sachs and J.P. Morgan acted as joint bookrunning managers on the offering. William Blair, UBS Investment Bank and Deutsche Bank Securities completed the underwriting syndicate.

Advisers

The Homburger team advising vVARDIS was led by Dieter Gericke and Daniel Häusermann. It also included Estelle Piccard, Luca Ellenberger, Magdalena Stock, Jasmin Künzle and Jana Waldvogel, all from the corporate/M&A and capital markets practices. Tax advice was provided by Reto Heuberger and Philippe Weber.

The Lenz & Staehelin team advising the underwriters was led by Patrick Schärli (capital markets). It also included Stephan Erni (corporate), as well as Kaan Saritas and Laura Wälchli, both from capital markets.

Pictured: Dieter Gericke (left) and Daniel Häusermann (right)

Axel Indigo

SHARE